AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$376M |
| 2 |
Honeywell
HON
|
+$325M |
| 3 |
Progressive
PGR
|
+$288M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$232M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLL
L3 Technologies, Inc.
LLL
|
+$529M |
| 2 |
RTX Corp
RTX
|
+$496M |
| 3 |
CVS Health
CVS
|
+$406M |
| 4 |
US Bancorp
USB
|
+$395M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$279M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.51% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.16% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OME
2526
DELISTED
Omega Protein
OME
| $546K | ﹤0.01% |
21,800
-4,600
| -17% | -$109K |
|
|
PDLI
2527
DELISTED
PDL BioPharma, Inc.
PDLI
| $546K | ﹤0.01% |
257,322
-42,400
| -14% | -$118K |
|
|
AMRI
2528
DELISTED
Albany Molecular Research Inc
AMRI
| $543K | ﹤0.01% |
28,950
| – | – |
|
2529
Marten Transport
MRTN
$1.21B
| $541K | ﹤0.01% |
58,035
+31,097
| +115% | +$280K |
|
2530
Alarm.com
ALRM
$2.71B
| $540K | ﹤0.01% |
19,400
+800
| +4% | +$23.2K |
|
|
CWEN.A
2531
DELISTED
Clearway Energy Class A
CWEN.A
| $539K | ﹤0.01% |
35,100
-8,200
| -19% | -$123K |
|
2532
Cameco
CCJ
$37.6B
| $536K | ﹤0.01% |
51,215
-1,257
| -2% | -$11.3K |
|
2533
Natural Gas Services Group
NGS
$472M
| $536K | ﹤0.01% |
16,677
| – | – |
|
|
KTWO
2534
DELISTED
K2M Group Holdings, Inc
KTWO
| $535K | ﹤0.01% |
26,690
-5,000
| -16% | -$95K |
|
2535
CVR Energy
CVI
$3.58B
| $533K | ﹤0.01% |
21,000
+1,300
| +7% | +$22.5K |
|
|
BKMU
2536
DELISTED
Bank Mutual Corp
BKMU
| $533K | ﹤0.01% |
56,400
+1,000
| +2% | +$8.48K |
|
2537
Teekay
TK
$1.01B
| $530K | ﹤0.01% |
66,000
+23,600
| +56% | +$182K |
|
|
XBKS
2538
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $526K | ﹤0.01% |
18,651
-85,129
| -82% | -$2.12M |
|
2539
Peoples Bancorp
PEBO
$1.5B
| $514K | ﹤0.01% |
15,820
+300
| +2% | +$8.3K |
|
2540
DHT Holdings
DHT
$2.99B
| $513K | ﹤0.01% |
123,800
| – | – |
|
2541
PDF Solutions
PDFS
$1.93B
| $512K | ﹤0.01% |
22,720
+1,600
| +8% | +$33.5K |
|
2542
Grupo Aeroportuario del Sureste
ASR
$8.27B
| $511K | ﹤0.01% |
+3,550
| New | +$536K |
|
|
CSLT
2543
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $509K | ﹤0.01% |
102,750
| – | – |
|
2544
Entravision Communication
EVC
$1.03B
| $506K | ﹤0.01% |
72,300
| – | – |
|
|
KDNY
2545
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $506K | ﹤0.01% |
8,880
| – | – |
|
2546
AMES National
ATLO
$271M
| $505K | ﹤0.01% |
15,310
+100
| +0.7% | +$2.99K |
|
|
EPZM
2547
DELISTED
Epizyme, Inc
EPZM
| $505K | ﹤0.01% |
41,700
| – | – |
|
|
SHLD
2548
DELISTED
Sears Holding Corporation
SHLD
| $504K | ﹤0.01% |
54,300
-1,920
| -3% | -$21.9K |
|
2549
AdvanSix
ASIX
$541M
| $502K | ﹤0.01% |
+22,657
| New | +$407K |
|
2550
SAP
SAP
$212B
| $502K | ﹤0.01% |
+5,803
| New | +$498K |
|
Similar funds
AllianceBernstein's Q4 2016 Portfolio in Review
As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
- AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
- AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
- AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
- AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
- AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.